Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Teder-Laving M, Metspalu A, Hadjigeorgiou GM, Polo O, Fietze I, Ross OA Wszolek Z, Butterworth AS, Soranzo N, Ouwehand WH, Roberts DJ, Danesh J, Allen RP, Earley CJ, Ondo WG, Xiong L, Montplaisir J, Gan-Or Z, Perola M, Vodicka P, Dina C, Franke A, Tittmann L, Stewart AF, Shah SH, Gieger C, Peters A, Rouleau GA, Berger K, Oexle K, Di Angelantonio E, Hinds DA, Müller-Myhsok B and Winkelmann J. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurology 2017. PubMed
Author: meron
RIC3 variants are not associated with Parkinson’s disease in French-Canadians and French.
Ross JP, Dupré N, Dauvilliers Y, Strong S, Dionne-Laporte A, Dion PA, Rouleau GA and Gan-Or Z. RIC3 variants are not associated with Parkinson’s disease in French-Canadians and French. Neurobiology of Aging. 2017. PubMed
Heterozygous PINK1 p.G411S in rapid eye movement sleep behavior disorder.
Gan-Or Z, Ruskey JA, Spiegelman D, Arnulf I, Dauvilliers Y, Högl B, Monaca CC, Postuma RB, Montplaisir JY and Rouleau GA. Heterozygous PINK1 p.G411S in rapid eye movement sleep behavior disorder. Brain. 2017. (letter). PubMed
KCNA2 mutations are rare in hereditary spastic paraplegia.
Gan-Or Z, Yoon G, Suchowersky O, Dupré N and Rouleau GA. KCNA2 mutations are rare in hereditary spastic paraplegia. Annals of Neurology. 2017. PubMed
Clinical and Genetic Study of Hereditary Spastic Paraplegia in Canada.
Chrestian N, Dupré N, Gan-Or Z, Szuto A, Chen S, Venkitachalam A, Brisson JD, Warman-Chardon J, Ahmed S, Ashtiani S, MacDonald H, Provencher P, Boycott K, Stavropoulos DJ, Dion PA, Ray PN, Suchowersky O, Rouleau GA and Yoon G. Clinical and Genetic Study of Hereditary Spastic Paraplegia in Canada. Neurology Genetics. 2017. PubMed
The dementia-associated APOE e4 allele is not associated with REM sleep behavior disorder.
Gan-Or Z, Montplaisir JY, Ross JP, Poirier J, Warby SC, Arnulf I, Strong S, Dauvilliers Y, Leblond CS, Hu MT, Högl B, Stefani A, Monaca CC, Cochen De Cock V, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Barber TR, Evetts SG, Rolinski M, Dion PA, Desautels A, Gagnon JF, Dupré N, Postuma RB and Rouleau GA. The dementia-associated APOE e4 allele is not associated with REM sleep behavior disorder. Neurobiology of Aging. 2017. PubMed
Dynamics of microtubules and their associated proteins: Recent insights and clinical implications.
Gan-Or Z and Guy A Rouleau. Dynamics of microtubules and their associated proteins: Recent insights and clinical implications. Neurology. 2016. (letter). PubMed
RNF213 is associated with Intracranial Aneurysms in the French-Canadian population.
Zhou S, Ambalavanan A, Rochefort D, Xie P, Bourassa CV, Hince P, Dionne-Laporte A, Spiegelman D, Gan-Or Z, Mirarchi C, Zaharieva V, Dupré N, Kobayashi H, Hitomi T, Harada K, Koizumi A, Xiong L, Dion PA and Rouleau GA. RNF213 is associated with Intracranial Aneurysms in the French-Canadian population. American Journal of Human Genetics. 2016. PubMed
A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated Hereditary Spastic Paraplegia.
(*equal contribution) Diomedi M*, Gan-Or Z*, Placidi F, Dion PA, Szuto A, Bengala M, Rouleau GA and Gigli GL. A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated Hereditary Spastic Paraplegia. European Journal of Medical Genetics. 2016. PubMed
Calpain 1 in neurodegeneration; a therapeutic target?
Gan-Or Z and Rouleau GA. Calpain 1 in neurodegeneration; a therapeutic target? Lancet Neurology. 2016. (letter). PubMed